A case of rheumatoid meningoencephalitis induced by pembrolizumab
- 17 August 2021
- journal article
- case report
- Published by Wiley in Neurology and Clinical Neuroscience
- Vol. 9 (6) , 470-473
Abstract
No abstract availableKeywords
Funding Information
- Japan Agency for Medical Research and Development (7211800049, 7211800130, 7211700121)
This publication has 6 references indexed in Scilit:
- Anti-cyclic citrullinated peptide antibody in the cerebrospinal fluid in patients with rheumatoid arthritis who have central nervous system involvementClinical Rheumatology, 2020
- Use of Cerebrospinal Fluid Biomarkers in Diagnosis and Monitoring of Rheumatoid MeningitisFrontiers in Neurology, 2019
- Neurological adverse events associated with immune checkpoint inhibitors: Review of the literatureEuropean Journal of Cancer, 2017
- Neurologic complications of immune checkpoint inhibitorsCurrent Opinion in Neurology, 2016
- Rheumatoid meningitis occurring during adalimumab and methotrexate treatmentJoint Bone Spine, 2012
- The HLA-DRB1*0401 Allele and the Development of Methotrexate-Induced Accelerated Rheumatoid NodulosisMedicine, 2001